title: Word of wisdom. Re: enzalutamide in metastatic prostate cancer before chemotherapy.
authors.affiliation: Department of Urology, Royal Melbourne Hospital, Melbourne, Australia.
authors.forename: Ken
authors.initials: K
authors.lastname: Chow
authors.affiliation: Department of Urology, Royal Melbourne Hospital, Melbourne, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia; Epworth Prostate Centre, Epworth Healthcare, Richmond, Australia. Electronic address: declan.murphy@petermac.org.
authors.forename: Declan G
authors.initials: DG
authors.lastname: Murphy
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D059002:Androgen Receptor Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D059002:Androgen Receptor Antagonists; D018931:Antineoplastic Agents, Hormonal; D010669:Phenylthiohydantoin